Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation

Leukemia and Lymphoma

Volumn 24, Issue 5-6, 1997, Pages 491-499

  Krüger, William ^a   Stockschläder, Marcus ^a   Sobottka, Ingo ^a   Betker, Renate ^a   De Wit, Maike ^a   Kröger, Nicolaus ^a   Grimm, Jan ^a   Arland, Malte ^a   Fiedler, Walter ^a   Erttmann, Rudolf ^a   Zander, Axel R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bone marrow transplantation; Fungal sepsis; Invasive mycosis; Liposomal amphotericin B; Neutropenia

Indexed keywords

AMINOTRANSFERASE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BILIRUBIN; CREATININE; CYCLOSPORIN A;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; CANDIDIASIS; CHILD; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERANCE; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEADACHE; HUMAN; IMMUNITY; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEROLOGY; STEM CELL TRANSPLANTATION; STEROID THERAPY; SYSTEMIC MYCOSIS; VEIN OCCLUSION;

EID: 8244230515     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709055586     Document Type: Article

References (20)

1. Nosari, A., Baberis, M., Landonio, G., Magnani, P., Majno, M., Oreste, P. and Sozzi, P. (1991) Infections in haematologic neoplasms: autopsy findings. Haematologica, 76, 135-140.
2. Vogelsang, G. B. and Wagner, J. E. (1990). Graft-versus-host disease. Hematological Oncological Clinics of North America, 4, 625-639.
3. Wade, J. C. (1993). Management of infection in patients with acute leukemia. Hematological Oncological Clinics of North America, 7, 293-315.
4. Walsh, T. J., Lee, J., Lecciones, J., Rubin, M., Butler, K., Francis, P., Weinberger, M., Roilides, E, Marshall, D., Gress, J and Pizzo, P. A. (1991). Empiric therapy with Amphotericin-B in febrile granulocytopenic patients. Reviews of Infectious Diseases, 13, 496-503.
5. Meyer, R. D. (1992). Current role of therapy with Amphotericin-B. Clinical Infectious Diseases, 14(Suppl. 1), 154-160.
6. Butler, W. T., Bennett, J. E., Elling, D. W., Wertlake, P. T, Utz, J. P. and Hill, G. J. (1964). Nephrotoxicity of Amphotericin-B - Early and late effects in 81 patients. Annals of Internal Medicine, 2, 175-187.
7. Douglas, J. B and Healy, K. J. (1968). Nephrotoxic effects of Amphotericin-B. includung renal acidosis. American Journal of Medicine, 46, 154-162.
8. Saral, R. (1991). Candida and Aspergillus infections in immunocompromised patients: An overview Reviews of Infectious Diseases, 13, 487-492.
9. Caillot, D., Casasnovas, O., Solary, E., Chavanet, P., Bonnotte, B., Reny, G., Entezam, F., Lopez, J., Bonnin, A. and Guy, H. (1993). Efficacy and tolerance of an Amphotericin-B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients. Journal of Antimicrobial Chemotherapy, 31, 161-169.
10. Lopez-Berenstein, G., Bodey, G. P., Fainstein, V., Keating, M., Frankel, L. S., Zeluff, B., Gentry, L. and Mehta, K. (1989). Treatment of systemic fungal infections with liposomal Amphotericin-B. Archives of Internal Medicine, 149, 2533-2536.
11. Emminger, W., Granmger, W., Emminger-Schmidtmeier, W., Zoubek, K., Pillwein, K., Susani, M., Wasserer, A. and Gadner, H. (1994). Tolerance of high doses of Amphotericin-B by infusion of a liposomal formulation in children with cancer. Annals of Hematology, 68, 27-31.
12. Coker, R., Tomlinson, D. and Harris, J (1991). Successful treatment of cryptococcal meningitis with liposomal Amphotericin-B after failure of treatment with fluconazole and conventional Amphotericin-B. AIDS, 5, 231-232.
13. Anaissie, E., Paetznick, V., Proffitt, R., Adler-Moore, J. and Bodey, G. P. (1991). Comparison of the in vitro antifungal activity of free and liposome encapsulated Amphotericin-B. European Journal of Clinical Microbiology and Infectious Diseases, 10, 665-668.
14. Hopfer, R. L., Mills, K., Mehta, R., Lopez-Berenstein, G., Fainstein, V. and Juliano, R.-L. (1984). In vitro antifungal activities of Amphotencin-B and Hposome-encapsulated Amphotericin-B. Antimicrobial Agents and Chemotherapy, 25, 387-389.
15. Karyotakis, N. C., Anaisse, E. J., Hachem, R., Dignani, M. C., Samonis, G. (1993). Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. Journal of Infetious Diseases, 5, 1311-1313.
16. Bearman, S. I., Appelbaum, F. R., Buckner, C. D., Petersen, F. B., Fisher, L. D., Clift, R. A. and Thomas, E. D. (1988). Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology, 6, 1562-1568.
17. Mills, W., Chopra, R., Linch, D. C. and Goldstone, A H. (1994). Liposomal Amphotericin-B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. British Journal of Haematology, 86, 754-760.
18. Chopra, R., Fielding, A. and Goldstone. A. H. (1996). Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome(- A report on 40 cases from a single centre. Leukemia and Lymphoma, 7 (Suppl.), 73-77.
19. Carreras, E., Grañena, C. and Rozman, C. (1993) Hepatic veno-occlusive disease after bone marrow transplant. Blood reviews, 7, 43-51.
20. Krüger, W. H., Sobottka, I., Stockschläder, M., Hoffknecht. M., Kruger, M, Rüβmann, B. C., Horstmann, M., Betker, R. and Zander, A. R. (1996). Short report: Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal amphotericin-B. A report of three cases with determination of the MIC-values. Scandinavian Journal of Infectious Diseases, in press.